Home > Boards > US OTC > Alternative Energy > United Health Products, Inc. (UEEC)

I really appreciate your at least topically respectful

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
StumpsOfMystery Member Profile
 
Followed By 0
Posts 185
Boards Moderated 0
Alias Born 08/21/19
160x600 placeholder
StumpsOfMystery   Friday, 10/18/19 07:05:17 PM
Re: 59SC post# 3622
Post # of 4201 
I really appreciate your at least topically respectful tone. Although I expect you mean to lure me into errors you will refute. If you are actually interested in answers, I do not have them. Not a specialist in this area. There are many hemostatic devices on the market--not just Surgigel. I would guess that the value of this product would have to do with any competitive advantage using it would give to one of the current producers over the rest of the market. It would be my guess that that advantage would have to be substantial. In other words, maybe 25% or more improvement overall against Surgigel. What additional sales would be made given the improvement? How would medical authorities respond to the introduction of a relatively 'new' product? Particularly one offered by a company with a somewhat questionable pedigree, with no recent revenues and facing 3 current lawsuits? (After all, anyone USING Hemostype would need to be reasonably sure the company backing it were financially secure). What would be the cost of a takeover? At the current market capitalization of $250M I would doubt many companies would feel it were worth the cost, to be honest.

Anyway, those are a few of my thoughts. I had promised another member to cease posting here as several are irked by my considerations. I may respond again if you ask questions. GLTA.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist